Intended for healthcare professionals

Letters The truth about Tamiflu?

Data access is matter of trust

BMJ 2010; 340 doi: (Published 13 January 2010) Cite this as: BMJ 2010;340:c134
  1. Alan R Maryon-Davis, president1
  1. 1UK Faculty of Public Health, London NW1 4LB
  1. president{at}

    The UK Faculty of Public Health strongly supports the BMJ’s call for mandatory disclosure of raw data of all trials cited in drug licensing applications and …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription